Cash flow Fresenius Medical Care AG

Stocks

FME

DE0005785802

Healthcare Facilities & Services

Market Closed - Xetra Other stock markets 01:35:18 18/06/26 am AEST			5-day change	1st Jan Change
41.38 ^EUR	+0.85%		+6.57%	+1.52%

09/06	FMC FRESENIUS MEDICAL CARE AG : UBS keeps a Sell rating	ZD
09/06	Clínica Baviera, the copy-paste machine

0d34055e4e4648ffb0e0ef.1TF1WYZ3_6nQrTCy5c03VWAKhPEpe-ukqgkGdilQ618.5QkyPcE1kJG32XjTs4xkASFt84l8OaDJk1hvOhAig2etaEwy3zuRkKLYZQ

Published financial data: FRESENIUS MEDICAL CARE AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Revenues	17.62B	19.4B	19.45B	19.34B	19.63B
Total Revenues	17.62B	19.4B	19.45B	19.34B	19.63B
Cost of Goods Sold, Total	12.54B	14.09B	14.53B	14.58B	14.6B
Gross Profit	5.08B	5.31B	4.93B	4.76B	5.03B
Selling General & Admin Expenses, Total	3.01B	3.51B	3.2B	3.14B	3.03B
Provision for Bad Debts	-	-	-	-	-
R&D Expenses	221M	229M	232M	183M	158M
Other Operating Expenses	-	-	-26.86M	-109M	-31.65M
Other Operating Expenses, Total	3.23B	3.73B	3.4B	3.22B	3.16B
Operating Income	1.84B	1.58B	1.52B	1.54B	1.87B
Interest Expense, Total	-354M	-360M	-425M	-407M	-384M
Interest And Investment Income	73.17M	67.66M	88.22M	71.58M	69.61M
Net Interest Expenses	-280M	-292M	-336M	-335M	-315M
Income (Loss) On Equity Invest.	92.18M	66.56M	122M	135M	181M
Currency Exchange Gains (Loss)	-	-	-35.5M	-23.06M	-43.79M
EBT, Excl. Unusual Items	1.66B	1.35B	1.27B	1.32B	1.69B
Restructuring Charges	-62.86M	-190M	-260M	-317M	-104M
Merger & Related Restructuring Charges	-	-24.37M	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	148M	14.67M	44.03M	-77.04M
Gain (Loss) On Sale Of Assets	-	-	4.84M	14.66M	993K
Asset Writedown	-36.55M	-118M	-	-	-
Other Unusual Items	15.43M	53.56M	-	-	-
EBT, Incl. Unusual Items	1.57B	1.22B	1.03B	1.06B	1.51B
Income Tax Expense	353M	325M	301M	316M	321M
Earnings From Continuing Operations	1.22B	894M	732M	741M	1.19B
Net Income to Company	1.22B	894M	732M	741M	1.19B
Minority Interest	-250M	-221M	-233M	-203M	-213M
Net Income - (IS)	969M	673M	499M	538M	978M
Net Income to Common Incl Extra Items	969M	673M	499M	538M	978M
Net Income to Common Excl. Extra Items	969M	673M	499M	538M	978M
Per Share Items
Net EPS - Basic	3.31	2.3	1.7	1.83	3.36
Basic EPS - Continuing Operations	3.31	2.3	1.7	1.83	3.36
Basic Weighted Average Shares Outstanding	293M	293M	293M	293M	291M
Net EPS - Diluted	3.31	2.3	1.7	1.83	3.36
Diluted EPS - Continuing Operations	3.31	2.3	1.7	1.83	3.36
Diluted Weighted Average Shares Outstanding	293M	293M	293M	293M	291M
Normalized Basic EPS	2.68	2.12	1.92	2.11	2.9
Normalized Diluted EPS	2.68	2.12	1.92	2.11	2.9
Dividend Per Share	1.35	1.12	1.19	1.44	1.49
Payout Ratio	40.49	58.74	65.86	64.91	43.19
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	2.69B	2.49B	2.38B	2.35B	2.62B
EBITA	1.95B	1.68B	1.62B	1.62B	1.95B
EBIT	1.84B	1.58B	1.52B	1.54B	1.87B
EBITDAR	2.77B	2.57B	2.47B	2.43B	2.7B
Total Revenues (As Reported)	17.62B	19.4B	19.45B	19.34B	19.63B
Effective Tax Rate - (Ratio)	22.45	26.65	29.1	29.9	21.22
Current Domestic Taxes	-11.68M	-5.42M	20.95M	69.97M	45.97M
Current Foreign Taxes	297M	372M	402M	319M	302M
Total Current Taxes	286M	366M	423M	389M	348M
Deferred Domestic Taxes	18.4M	16.96M	34.02M	-37.76M	11.03M
Deferred Foreign Taxes	48.86M	-58.43M	-156M	-34.91M	-38.24M
Total Deferred Taxes	67.26M	-41.47M	-122M	-72.67M	-27.21M
Normalized Net Income	785M	623M	562M	619M	845M
Interest Capitalized	4.17M	2.24M	2.5M	2.15M	1.58M
Interest on Long-Term Debt	147M	154M	151M	151M	145M
Non-Cash Pension Expense	11.41M	11.42M	23.18M	23.65M	23.38M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	221M	229M	232M	183M	158M
Net Rental Expense, Total	80.26M	83.64M	91.98M	79.5M	82.29M
Imputed Operating Lease Interest Expense	17.88M	18.28M	24.86M	22.55M	23.3M
Imputed Operating Lease Depreciation	62.38M	65.37M	67.12M	56.95M	58.99M
Stock-Based Comp., Other (Total)	28.29M	-5.87M	32.52M	38.46M	45.12M
Total Stock-Based Compensation	28.29M	-5.87M	32.52M	38.46M	45.12M

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Assets
Cash And Equivalents	1.48B	1.27B	1.4B	1.18B	1.6B
Short Term Investments	159M	188M	154M	163M	141M
Total Cash And Short Term Investments	1.64B	1.46B	1.56B	1.34B	1.74B
Accounts Receivable, Total	3.58B	3.72B	3.64B	3.41B	3.18B
Other Receivables	307M	293M	361M	419M	407M
Notes Receivable	18.87M	18.3M	12.66M	48.05M	65.42M
Total Receivables	3.91B	4.03B	4.01B	3.88B	3.65B
Inventory	2.04B	2.3B	2.18B	2.07B	2.14B
Prepaid Expenses	35.4M	43.2M	45.76M	41.62M	9.84M
Other Current Assets, Total	346M	371M	907M	594M	360M
Total Current Assets	7.97B	8.2B	8.7B	7.92B	7.9B
Gross Property Plant And Equipment	16.65B	17.94B	17.91B	18.79B	17.68B
Accumulated Depreciation	-8.1B	-9.6B	-10.45B	-11.53B	-11.18B
Net Property Plant And Equipment	8.55B	8.34B	7.45B	7.26B	6.5B
Long-term Investments	787M	774M	1.08B	1.12B	1.06B
Goodwill	14.36B	15.79B	14.65B	15.17B	13.57B
Other Intangibles, Total	1.46B	1.52B	1.36B	1.37B	1.25B
Accounts Receivable Long-Term	149M	142M	123M	112M	102M
Deferred Tax Assets Long-Term	315M	313M	284M	230M	237M
Other Long-Term Assets, Total	776M	673M	275M	379M	384M
Total Assets	34.37B	35.75B	33.93B	33.57B	31B
Liabilities
Accounts Payable, Total	819M	893M	839M	956M	820M
Accrued Expenses, Total	1.29B	1.21B	1.22B	1.27B	1.32B
Short-term Borrowings	1.26B	669M	484M	27.42M	29.98M
Current Portion of Long-Term Debt	668M	694M	488M	575M	1.6B
Current Portion of Leases	662M	674M	617M	641M	584M
Current Income Taxes Payable	138M	144M	191M	143M	140M
Unearned Revenue Current, Total	518M	106M	85.82M	82.16M	114M
Other Current Liabilities	1.91B	2.08B	2.18B	1.97B	1.64B
Total Current Liabilities	7.26B	6.47B	6.11B	5.66B	6.25B
Long-Term Debt	6.65B	7.17B	6.96B	6.26B	5.69B
Long-Term Leases	4.09B	4B	3.53B	3.5B	2.91B
Unearned Revenue Non Current	5K	-	-	-	-
Pension & Other Post Retirement Benefits	783M	514M	664M	679M	575M
Deferred Tax Liability Non Current	868M	936M	750M	709M	690M
Other Non Current Liabilities	744M	1.21B	1.09B	990M	612M
Total Liabilities	20.39B	20.3B	19.1B	17.8B	16.72B
Common Stock, Total	293M	293M	293M	293M	293M
Additional Paid In Capital	2.89B	3.37B	3.38B	3.35B	3.08B
Retained Earnings	10.83B	10.71B	10.92B	11.27B	12.21B
Treasury Stock	-	-	-	-	-586M
Comprehensive Income and Other	-1.31B	-388M	-975M	-329M	-1.68B
Total Common Equity	12.7B	13.99B	13.62B	14.58B	13.31B
Minority Interest	1.28B	1.46B	1.21B	1.19B	973M
Total Equity	13.98B	15.45B	14.83B	15.77B	14.28B
Total Liabilities And Equity	34.37B	35.75B	33.93B	33.57B	31B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	293M	293M	293M	293M	279M
ECS Total Common Shares Outstanding	293M	293M	293M	293M	279M
Book Value / Share	43.34	47.68	46.42	49.68	47.66
Tangible Book Value	-3.12B	-3.32B	-2.39B	-1.96B	-1.52B
Tangible Book Value Per Share	-10.66	-11.32	-8.15	-6.69	-5.43
Total Debt	13.32B	13.21B	12.08B	11B	10.81B
Net Debt	11.68B	11.75B	10.52B	9.66B	9.07B
Debt Equivalent of Unfunded Proj. Benefit Obligation	749M	483M	634M	657M	555M
Debt Equivalent Oper. Leases	642M	669M	736M	636M	658M
Minority Interest, Total (Incl. Fin. Div)	1.28B	1.46B	1.21B	1.19B	973M
Equity Method Investments, Total	787M	774M	643M	621M	664M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	247M	307M	362M	344M	329M
Inventories - Work In Process, Total	105M	124M	133M	124M	147M
Inventories - Finished Goods, Total	1.69B	1.86B	1.68B	1.6B	1.66B
Land - (BS)	70.69M	69.16M	65.65M	63.13M	71.52M
Buildings, Total	4.13B	4.37B	4.31B	4.58B	4.41B
Machinery, Total	5.68B	6.16B	6.23B	6.42B	6.04B
Full Time Employees	123K	128K	120K	112K	110K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	164M	169M	262M	206M	208M

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Net Income	969M	673M	499M	538M	978M
Depreciation & Amortization - CF	1.43B	1.55B	1.46B	1.4B	1.32B
Amortization of Goodwill and Intangible Assets - (CF)	103M	107M	95.85M	84.49M	77.99M
Depreciation & Amortization, Total	1.54B	1.66B	1.56B	1.48B	1.4B
Amortization of Deferred Charges, Total - (CF)	49.79M	61.85M	56.49M	52.7M	63.24M
(Gain) Loss From Sale Of Asset	44.09M	-99.27M	-12.9M	-12.17M	123M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	38.31M	118M	139M	207M	37M
(Income) Loss On Equity Investments - (CF)	-92.18M	-66.56M	-122M	-135M	-181M
Stock-Based Compensation (CF)	-	-	-	-	-
Other Operating Activities, Total	42.37M	-50.5M	-48.76M	-191M	122M
Change In Accounts Receivable	-163M	-46.68M	-152M	-73.48M	-69.06M
Change In Inventories	-48.53M	-204M	-13.14M	108M	-249M
Change In Accounts Payable	-364M	-357M	108M	156M	12.45M
Change In Income Taxes	314M	326M	472M	482M	237M
Change in Other Net Operating Assets	164M	154M	146M	-228M	207M
Cash from Operations	2.49B	2.17B	2.63B	2.39B	2.68B
Capital Expenditure	-854M	-724M	-685M	-699M	-915M
Sale of Property, Plant, and Equipment	24.42M	36.2M	16.14M	14.1M	16.7M
Cash Acquisitions	-325M	10.53M	-3.14M	-177K	-15.3M
Divestitures	52.44M	60.16M	172M	630M	202M
Sale (Purchase) of Intangible assets	-32.36M	-46.35M	-26.37M	-8.54M	-4.67M
Investment in Marketable and Equity Securities, Total	-61.58M	-71.28M	-18.46M	-20.71M	-6.03M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-1.2B	-735M	-544M	-84.94M	-723M
Short Term Debt Issued, Total	1.8B	717M	65.34M	84.81M	156M
Long-Term Debt Issued, Total	1.24B	1.08B	418M	61.51M	1.62B
Total Debt Issued	3.05B	1.8B	483M	146M	1.78B
Short Term Debt Repaid, Total	-627M	-1.3B	-245M	-540M	-141M
Long-Term Debt Repaid, Total	-2.78B	-1.52B	-1.5B	-1.53B	-1.49B
Total Debt Repaid	-3.41B	-2.82B	-1.74B	-2.07B	-1.63B
Issuance of Common Stock	6.51M	20.15M	-	-	-
Repurchase of Common Stock	-	-	-	-	-585M
Common Dividends Paid	-392M	-396M	-329M	-349M	-423M
Common & Preferred Stock Dividends Paid	-392M	-396M	-329M	-349M	-423M
Other Financing Activities, Total	-280M	-219M	-271M	-292M	-545M
Cash from Financing	-1.02B	-1.62B	-1.86B	-2.57B	-1.4B
Foreign Exchange Rate Adjustments	131M	-23.16M	-72.61M	26.2M	-141M
Net Change in Cash	400M	-208M	153M	-242M	414M
Supplemental Items
Cash Interest Paid	342M	351M	395M	381M	360M
Cash Income Tax Paid (Refund)	345M	335M	410M	445M	226M
Levered Free Cash Flow	1.66B	1.05B	1.31B	2.03B	1.56B
Unlevered Free Cash Flow	1.88B	1.27B	1.58B	2.29B	1.8B
Change In Net Working Capital	-890K	657M	309M	-457M	-39.52M
Net Debt Issued / Repaid	-359M	-1.02B	-1.26B	-1.93B	150M

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Profitability
Return on Assets	3.49	2.81	2.73	2.85	3.62
Return on Total Capital	4.43	3.52	3.43	3.58	4.51
Return On Equity %	9.27	6.08	4.84	4.84	7.93
Return on Common Equity	8.11	5.05	3.61	3.82	7.02
Margin Analysis
Gross Profit Margin %	28.82	27.38	25.32	24.6	25.62
SG&A Margin	17.1	18.07	16.43	16.25	15.45
EBITDA Margin %	15.26	12.83	12.23	12.14	13.36
EBITA Margin %	11.05	8.68	8.32	8.4	9.92
EBIT Margin %	10.47	8.12	7.83	7.96	9.53
Income From Continuing Operations Margin %	6.92	4.61	3.77	3.83	6.07
Net Income Margin %	5.5	3.47	2.56	2.78	4.98
Net Avail. For Common Margin %	5.5	3.47	2.56	2.78	4.98
Normalized Net Income Margin	4.46	3.21	2.89	3.2	4.31
Levered Free Cash Flow Margin	9.42	5.4	6.74	10.5	7.93
Unlevered Free Cash Flow Margin	10.67	6.56	8.11	11.82	9.15
Asset Turnover
Asset Turnover	0.53	0.55	0.56	0.57	0.61
Fixed Assets Turnover	2.11	2.3	2.46	2.63	2.85
Receivables Turnover (Average Receivables)	5.15	5.31	5.29	5.49	5.96
Inventory Turnover (Average Inventory)	6.38	6.5	6.49	6.87	6.94
Short Term Liquidity
Current Ratio	1.1	1.27	1.42	1.4	1.26
Quick Ratio	0.76	0.85	0.91	0.91	0.85
Operating Cash Flow to Current Liabilities	0.34	0.34	0.43	0.42	0.43
Days Sales Outstanding (Average Receivables)	70.89	68.68	69.03	66.69	61.23
Days Outstanding Inventory (Average Inventory)	57.24	56.15	56.22	53.31	52.61
Average Days Payable Outstanding	23.21	21.77	21.93	22.7	22.09
Cash Conversion Cycle (Average Days)	104.91	103.06	103.31	97.3	91.75
Long Term Solvency
Total Debt/Equity	95.29	85.52	81.46	69.79	75.68
Total Debt / Total Capital	48.79	46.1	44.89	41.1	43.08
LT Debt/Equity	76.79	72.34	70.74	61.9	60.2
Long-Term Debt / Total Capital	39.32	38.99	38.99	36.46	34.27
Total Liabilities / Total Assets	59.32	56.79	56.3	53.02	53.93
EBIT / Interest Expense	5.22	4.38	3.59	3.78	4.86
EBITDA / Interest Expense	9.56	8.98	7.25	7.42	8.51
(EBITDA - Capex) / Interest Expense	7.14	6.97	5.64	5.71	6.13
Total Debt / EBITDA	3.94	4.09	3.92	3.64	3.31
Net Debt / EBITDA	3.46	3.63	3.42	3.2	2.77
Total Debt / (EBITDA - Capex)	5.27	5.26	5.04	4.74	4.59
Net Debt / (EBITDA - Capex)	4.62	4.68	4.39	4.16	3.85
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-1.35	10.1	0.29	-0.61	1.51
Gross Profit, 1 Yr. Growth %	-8.34	4.56	0.64	-3.42	5.72
EBITDA, 1 Yr. Growth %	-16.46	-7.55	-2.88	-1.36	11.75
EBITA, 1 Yr. Growth %	-21.53	-13.61	-1.56	0.28	19.95
EBIT, 1 Yr. Growth %	-22.5	-14.61	-0.94	1.04	21.47
Earnings From Cont. Operations, 1 Yr. Growth %	-15.1	-26.64	-18.1	1.15	60.79
Net Income, 1 Yr. Growth %	-16.75	-30.53	-25.9	7.8	81.88
Normalized Net Income, 1 Yr. Growth %	-24.85	-20.77	-2.37	10.12	36.43
Diluted EPS Before Extra, 1 Yr. Growth %	-16.44	-30.6	-25.97	7.65	83.6
Accounts Receivable, 1 Yr. Growth %	9.71	3.89	-2.2	-6.29	-6.84
Inventory, 1 Yr. Growth %	7.53	12.67	-5.1	-5.11	3.52
Net Property, Plant and Equip., 1 Yr. Growth %	4.45	-2.48	-10.62	-2.62	-10.45
Total Assets, 1 Yr. Growth %	8.45	4.04	-5.1	-1.07	-7.64
Tangible Book Value, 1 Yr. Growth %	-0.08	6.35	-27.96	-17.89	-22.81
Common Equity, 1 Yr. Growth %	13.23	10.16	-2.64	7.02	-8.69
Cash From Operations, 1 Yr. Growth %	-41.19	-12.94	21.29	-9.23	12.36
Capital Expenditures, 1 Yr. Growth %	-18.79	-15.26	-5.44	2.16	30.89
Levered Free Cash Flow, 1 Yr. Growth %	-29.6	-36.97	28.29	54.8	-23.37
Unlevered Free Cash Flow, 1 Yr. Growth %	-28.05	-32.41	26.42	44.88	-21.39
Dividend Per Share, 1 Yr. Growth %	0.75	-17.04	6.25	21.01	3.47
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.41	4.22	5.08	-0.16	0.45
Gross Profit, 2 Yr. CAGR %	-3	-2.07	1.58	-1.41	1.05
EBITDA, 2 Yr. CAGR %	-7.41	-12.65	-7.8	-3.34	3.76
EBITA, 2 Yr. CAGR %	-10.29	-18.31	-11.25	-2.46	7.81
EBIT, 2 Yr. CAGR %	-10.14	-18.58	-10.54	0.05	10.78
Earnings From Cont. Operations, 2 Yr. CAGR %	-7.94	-21.08	-22.49	-8.98	27.53
Net Income, 2 Yr. CAGR %	-10.11	-23.95	-28.25	-10.62	40.02
Normalized Net Income, 2 Yr. CAGR %	-9.84	-22.74	-17	3.69	22.57
Diluted EPS Before Extra, 2 Yr. CAGR %	-8.59	-23.85	-28.32	-10.73	40.58
Accounts Receivable, 2 Yr. CAGR %	-0.16	6.76	0.8	-4.27	-6.57
Inventory, 2 Yr. CAGR %	10.69	10.07	3.41	-5.1	-0.89
Net Property, Plant and Equip., 2 Yr. CAGR %	0.21	0.93	-6.64	-6.71	-6.62
Total Assets, 2 Yr. CAGR %	2.15	6.22	-0.64	-3.11	-4.41
Tangible Book Value, 2 Yr. CAGR %	-5.36	3.08	-12.47	-23.09	-20.39
Common Equity, 2 Yr. CAGR %	3.05	11.69	3.56	2.08	-1.15
Cash From Operations, 2 Yr. CAGR %	-1.52	-28.45	2.76	4.93	0.99
Capital Expenditures, 2 Yr. CAGR %	-12.85	-17.04	-10.48	-1.72	15.63
Levered Free Cash Flow, 2 Yr. CAGR %	19.32	-33.35	-12.06	40.92	8.91
Unlevered Free Cash Flow, 2 Yr. CAGR %	13.01	-30.23	-9.3	35.34	6.72
Dividend Per Share, 2 Yr. CAGR %	6.07	-8.58	-6.11	13.39	11.9
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.11	3.54	2.89	3.15	0.39
Gross Profit, 3 Yr. CAGR %	-0.51	-0.53	-3.83	-0.11	0.91
EBITDA, 3 Yr. CAGR %	-2.58	-7.43	-9.97	-5.7	1.45
EBITA, 3 Yr. CAGR %	-5.09	-11.39	-13.73	-7.57	4.5
EBIT, 3 Yr. CAGR %	-5.48	-11.63	-13.79	-6.84	6.73
Earnings From Cont. Operations, 3 Yr. CAGR %	-18.18	-14.65	-20.1	-15.3	10.03
Net Income, 3 Yr. CAGR %	-21.21	-17.51	-24.61	-17.82	13.26
Normalized Net Income, 3 Yr. CAGR %	-7.09	-13.6	-18.62	-8.79	13.62
Diluted EPS Before Extra, 3 Yr. CAGR %	-19.95	-16.61	-24.56	-17.92	13.53
Accounts Receivable, 3 Yr. CAGR %	1.44	1.17	3.69	-1.62	-5.13
Inventory, 3 Yr. CAGR %	11.59	11.35	4.76	0.49	-2.31
Net Property, Plant and Equip., 3 Yr. CAGR %	30.63	-0.69	-3.08	-5.32	-7.97
Total Assets, 3 Yr. CAGR %	9.41	2.78	2.3	-0.78	-4.64
Tangible Book Value, 3 Yr. CAGR %	40.22	-1.61	-8.52	-14.31	-23
Common Equity, 3 Yr. CAGR %	2.6	5.37	6.69	4.7	-1.65
Cash From Operations, 3 Yr. CAGR %	6.48	-5.48	-14.68	-1.4	7.35
Capital Expenditures, 3 Yr. CAGR %	-6.86	-13.66	-13.34	-6.46	8.13
Levered Free Cash Flow, 3 Yr. CAGR %	31.91	-3.52	-17.72	6.18	15.02
Unlevered Free Cash Flow, 3 Yr. CAGR %	23.3	-4.77	-15.47	6.02	12.92
Dividend Per Share, 3 Yr. CAGR %	4.89	-2.27	-3.88	2.17	9.98
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.24	1.75	3.29	2.04	1.91
Gross Profit, 5 Yr. CAGR %	-2	-2.47	-0.91	-2.49	-1.91
EBITDA, 5 Yr. CAGR %	-2.41	-3.69	-3.94	-5.64	-4.26
EBITA, 5 Yr. CAGR %	-4.45	-6.69	-6.59	-7.66	-5.04
EBIT, 5 Yr. CAGR %	-4.62	-7.01	-6.95	-7.58	-4.69
Earnings From Cont. Operations, 5 Yr. CAGR %	-3.01	-10.47	-19.93	-12.43	-3.67
Net Income, 5 Yr. CAGR %	-3.26	-12.05	-24.11	-14.82	-3.42
Normalized Net Income, 5 Yr. CAGR %	-4.6	-8.21	-10.49	-8.51	-4.14
Diluted EPS Before Extra, 5 Yr. CAGR %	-2.37	-11.2	-23.41	-14.31	-3.23
Accounts Receivable, 5 Yr. CAGR %	-0.66	1.22	1.18	-1.04	-0.54
Inventory, 5 Yr. CAGR %	8.79	12.21	8.24	4.45	2.47
Net Property, Plant and Equip., 5 Yr. CAGR %	19.03	19.02	14.21	-3.14	-4.51
Total Assets, 5 Yr. CAGR %	6.15	8.28	5.27	0.38	-0.44
Tangible Book Value, 5 Yr. CAGR %	-3.76	2.28	16.13	-10.84	-13.47
Common Equity, 5 Yr. CAGR %	4.94	7.33	2.98	4.04	3.48
Cash From Operations, 5 Yr. CAGR %	5.2	-0.22	4.98	-1.45	-8.73
Capital Expenditures, 5 Yr. CAGR %	-1.69	-5.18	-8.33	-9.07	-2.74
Levered Free Cash Flow, 5 Yr. CAGR %	2.26	-1.55	12.66	11.75	-7.96
Unlevered Free Cash Flow, 5 Yr. CAGR %	1.44	-1.79	9.48	9.19	-7.21
Dividend Per Share, 5 Yr. CAGR %	7.06	1.11	0.34	3.71	2.14